{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-009249","form_type":"8-K","ticker":"KOAN","cik":"0000897078","company_name":"Resonate Blends, Inc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.219957+00:00","generated_at":"2026-06-05T02:15:35.072510+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Resonate Blends amends EMGE deal minimum to $250K; issues 9.6M anti-dilution shares","bullets":["Amendment reduces minimum investment from $500K to $250K before closing of Emergent Health Corp. exchange.","Issued 9,555,435 common shares as anti-dilution protection under Membership Interest Purchase Agreements.","Shares issued to officers and directors, including CEO Geoffrey Selzer and David Thielen.","Issuance was exempt under Section 4(a)(2) and Rule 506(b) of the Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-009249","json":"https://secwatch.observer/filing/0001493152-24-009249.json","markdown":"https://secwatch.observer/filing/0001493152-24-009249.md","text":"https://secwatch.observer/filing/0001493152-24-009249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/897078/000149315224009249/0001493152-24-009249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/897078/000149315224009249/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T02:15:35.072510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e00afb48c02ad13fd383b77a06caba41c721275","claim":"Resonate Blends, Inc. amended Share Exchange Agreement with Emergent Health Corp. valued at Amendment revised Sections 1.03(d)(v) and 5.05 of the Exchange Agreement to require a minimum invest (effective 2024-03-04).","evidence_excerpt":"On March 4, 2024, Resonate Blends, Inc. (“ we ” or the “ Company ”) entered into an amendment (the “ Amendment ”) to the Share Exchange Agreement (the “ Exchange Agreement ”) with Emergent Health Corp. (“ EMGE ”) and the holders of Series Class A Preferred Stock, the Series C Convertible Non-Voting Preferred Stock and the Class F Preferred Stock of EMGE. The Amendment revised Sections 1.03(d)(v) and 5.05 of the Exchange Agreement to require a minimum investment of $250,000 instead of $500,000 prior to Closing.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/897078/000149315224009249/0001493152-24-009249-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Emergent Health Corp."},{"label":"Value","value":"Amendment revised Sections 1.03(d)(v) and 5.05 of the Exchange Agreement to require a minimum invest"},{"label":"Effective","value":"2024-03-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}